Facebook
Twitter
LinkedIn
ForwardIdentifying and Treating Opioid Use Disorder
| Registration |
|---|
If you have questions, please contact Norma Haskins at 515-283-9343. Upcoming Webinars
|
Target Audience
Physicians, healthcare professionals, quality improvement managers, and other interested entities across all healthcare settings and IHC programs including HIIN, TCPI and SIM.
Program Overview
Identifying patients with opioid use disorder can be challenging. This session will focus on how to identify a patient with opioid use disorder and how to initiate treatment once opioid use disorder has been identified.
Learning objecives
- Examine tools available to identify opioid use disorder.
- Discuss medication assisted treatment and how it assists with treatment and relapse prevention.
- Outline tips and tricks for setting up a medication assisted treatment program.
Speakers
Nicole Gastala, MD is a graduate of Loyola University Stritch School of Medicine in Chicago and completed her residency at the University of Iowa in Family Medicine. She was chief resident in her third year and is board certified in family medicine. Dr. Gastala was also a visiting scholar at the Robert Graham Center in Washington, DC where she focused on health policy analysis relevant to primary care and family medicine. She is currently a family physician at Primary Health Care, Inc. in Marshalltown, IA. Her interests include treating whole family, including women's health, children, adults, and the elderly with a special focus on preventative healthcare, group visits, chronic pain, and medication-assisted treatment.
Andrea Storjohann, RN, CADC, is a medication-assisted treatment (MAT) coordinator/pain management nurse who works with Primary Health Care, Inc. and partners with the Substance Abuse Treatment Unit of Central Iowa in Marshalltown. She coordinates with treatment centers across the state ensuring MAT clients have access and meet their substance abuse requirement. Storjohann has spent more than ten years in healthcare - the last five years dealing with pain management, opiates, and addiction. She understands the impact substance use and dependence has on the community, individuals, and family. She is a registered nurse and a Certified Alcohol Drug Counselor (CADC).
Disclosures
Relevant to the content of this educational activity, the following individuals have no conflict of interests with commercial interests to disclose.
- Ellyn Cottingham, Planning Committee Member
- Nicky Carlson, Planning Committee Member
- Sarah Derr, Planning Committee Member
- Nicole Gastala, MD, Speaker
- Andrea Storjohann, RN, CADC, Speaker
Continuing Education Credit
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Healthcare Collaborative. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.- Other Health Professionals: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)TM.
Educational Grants
No commercial interest company provided financial support for this continuing education activity.
Disclaimer
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
Available Credit
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 2A
- 1.00 CE Contact Hour(s)
Price
There is no cost to attend.
If you have questions, please contact Norma Haskins at 515-283-9343.
Upcoming Webinars
- August 1 – Opioid Standard of Care and Litigation
- August 29 – Community Interventions and Stories from the Field Stories from the Field
- September 12 – Tools to Address the Tools to Epidemic